A carregar...

SWOG0919: A Phase 2 Study of Idarubicin and Cytarabine in Combination with Pravastatin for Relapsed Acute Myeloid Leukaemia

Inhibition of cholesterol synthesis and uptake sensitizes acute myeloid leukaemia (AML) blasts to chemotherapy. A Phase 1 study demonstrated the safety of high dose pravastatin given with idarubicin and cytarabine in patients with AML and also demonstrated an encouraging response rate. The Southwest...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Advani, Anjali S., McDonough, Shannon, Copelan, Edward, Willman, Cheryl, Mulford, Deborah A., List, Alan F., Sekeres, Mikkael A., Othus, Megan, Appelbaum, Frederick R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4188732/
https://ncbi.nlm.nih.gov/pubmed/25039477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!